Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 26379868 |
US |
1 | |
Drug dose omission by device, Product use issue, Device leakage, |
||||
SOMATROPIN, |
||||
| 902 | 26369114 |
US |
||
Wheezing, Drug dose omission by device, Device delivery system issue, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 903 | 26369275 |
US |
2 | |
Drug dose omission by device, Circumstance or information capable of leading to medication error, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 904 | 26369418 |
US |
2 | |
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 905 | 26369423 |
US |
85 | 2 |
Drug dose omission by device, Device difficult to use, Accidental exposure to product, Injection site injury, |
||||
EVOLOCUMAB, |
||||
| 906 | 26369830 |
US |
28 | |
Drug dose omission by device, Device difficult to use, Migraine, |
||||
ERENUMAB-AOOE, |
||||
| 907 | 26369902 |
US |
78 | 2 |
Injection site rash, Injection site pruritus, Product preparation error, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 908 | 26370855 |
US |
72 | |
Asthma, Bronchitis, Drug dose omission by device, Wrong technique in product usage process, Device deposit issue, |
||||
ALBUTEROL SULFATE, |
||||
| 909 | 26370857 |
US |
34 | |
Drug dose omission by device, Device delivery system issue, Device malfunction, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 910 | 26370868 |
US |
50 | |
Drug dose omission by device, Device delivery system issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 911 | 26371530 |
US |
||
Illness, Dyspnoea, Hypersensitivity, Device delivery system issue, Drug dose omission by device, Wrong technique in product usage process, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST, |
||||
| 912 | 26371590 |
US |
16 | |
Hypoaesthesia oral, Accidental exposure to product, Device malfunction, Drug dose omission by device, Device malfunction, |
||||
FREMANEZUMAB-VFRM, |
||||
| 913 | 26371734 |
US |
32 | |
Drug dose omission by device, Device issue, Off label use, |
||||
RISPERIDONE, RISPERIDONE, CLONIDINE, |
||||
| 914 | 26372088 |
US |
1 | |
Skin swelling, Pruritus, Drug dose omission by device, |
||||
DUPILUMAB, |
||||
| 915 | 26372293 |
US |
11 | 1 |
Drug dose omission by device, Device defective, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 916 | 26372297 |
US |
11 | 2 |
Drug dose omission by device, Device delivery system issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 917 | 26372311 |
US |
||
Injection site haemorrhage, Drug dose omission by device, Device malfunction, |
||||
FREMANEZUMAB-VFRM, |
||||
| 918 | 26372742 |
US |
||
Drug dose omission by device, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 919 | 26373366 |
US |
17 | 1 |
Drug dose omission by device, Device power source issue, |
||||
SOMATROPIN, |
||||
| 920 | 26373738 |
US |
2 | |
Drug dose omission by device, Device defective, |
||||
GUSELKUMAB, |
||||
| 921 | 26373759 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 922 | 26373779 |
US |
85 | 2 |
Device difficult to use, Device use error, Inappropriate schedule of product administration, Off label use, Migraine, Drug dose omission by device, |
||||
ERENUMAB-AOOE, |
||||
| 923 | 26373904 |
AU |
2 | |
Toxic nodular goitre, Nerve compression, Macular degeneration, Device defective, Drug dose omission by device, |
||||
ETANERCEPT, |
||||
| 924 | 26364274 |
US |
52 | 2 |
Arthralgia, Migraine, Device difficult to use, Drug dose omission by device, |
||||
ERENUMAB-AOOE, |
||||
| 925 | 26364456 |
US |
65 | 1 |
Asthma, Device delivery system issue, Drug dose omission by device, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 926 | 26364743 |
US |
||
Drug dose omission by device, Device delivery system issue, Device malfunction, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 927 | 26365469 |
US |
||
Drug dose omission by device, Device delivery system issue, Wrong technique in product usage process, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 928 | 26365869 |
US |
54 | 1 |
Knee arthroplasty, Arthralgia, Device difficult to use, Drug dose omission by device, Therapeutic product effect decreased, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 929 | 26366747 |
US |
||
Arthritis, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 930 | 26366748 |
US |
||
Drug dose omission by device, Device breakage, Device difficult to use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 931 | 26366749 |
US |
||
Drug dose omission by device, Device delivery system issue, Device malfunction, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 932 | 26366944 |
US |
10 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 933 | 26366959 |
KR |
13 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 934 | 26366966 |
GB |
51 | 2 |
Drug dose omission by device, Device issue, Device material issue, Device breakage, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 935 | 26366991 |
CO |
1 | |
Drug dose omission by device, Device leakage, Device use error, |
||||
SOMATROPIN, |
||||
| 936 | 26366997 |
KR |
7 | 2 |
Device use error, Device material issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 937 | 26367041 |
US |
46 | 2 |
Wrong technique in product usage process, Device difficult to use, Drug dose omission by device, Migraine, |
||||
ERENUMAB-AOOE, |
||||
| 938 | 26367090 |
US |
43 | 2 |
Device malfunction, Device issue, Device leakage, Incorrect dose administered by device, Drug dose omission by device, |
||||
SECUKINUMAB, SECUKINUMAB, FOLIC ACID, |
||||
| 939 | 26367159 |
PA |
18 | 1 |
Device information output issue, Drug dose omission by device, Device breakage, |
||||
SOMATROPIN, |
||||
| 940 | 26367579 |
US |
2 | |
Blood glucose increased, Drug dose omission by device, |
||||
INSULIN GLARGINE, |
||||
| 941 | 26367770 |
US |
2 | |
Pollakiuria, Drug dose omission by device, Device operational issue, |
||||
INSULIN GLARGINE, |
||||
| 942 | 26367997 |
US |
1 | |
Drug dose omission by device, Needle issue, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 943 | 26363135 |
US |
1 | |
Device malfunction, Accidental exposure to product, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 944 | 26363147 |
US |
93 | |
Off label use, Drug dose omission by device, Device mechanical issue, Device defective, Wrong technique in device usage process, Product substitution issue, |
||||
TIOTROPIUM BROMIDE, |
||||
| 945 | 26363947 |
US |
59 | 2 |
Device use error, Needle issue, Drug dose omission by device, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 946 | 26362375 |
US |
2 | |
Accidental exposure to product, Device leakage, Drug dose omission by device, Exposure via skin contact, Device delivery system issue, Device defective, |
||||
SECUKINUMAB, |
||||
| 947 | 26362601 |
US |
1 | |
Accidental exposure to product, Drug dose omission by device, Exposure via skin contact, Drug delivery system malfunction, Device leakage, |
||||
SECUKINUMAB, |
||||
| 948 | 26362808 |
US |
80 | 1 |
Hypoacusis, Drug dose omission by device, Device difficult to use, Wrong technique in product usage process, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 949 | 26357913 |
US |
66 | 2 |
Injection site pain, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 950 | 26358161 |
US |
||
Dyspnoea, Illness, Malaise, Adverse event, Drug dose omission by device, Wrong technique in device usage process, Device delivery system issue, Dizziness, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 951 | 26358343 |
US |
60 | 2 |
Injection site pain, Injection site erythema, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 952 | 26359015 |
US |
23 | 2 |
Migraine, Injection site haemorrhage, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, |
||||
| 953 | 26359154 |
US |
75 | 2 |
Drug dose omission by device, Migraine with aura, |
||||
ERENUMAB-AOOE, |
||||
| 954 | 26359275 |
US |
||
Drug dose omission by device, Device delivery system issue, Product barcode issue, Product knowledge deficit, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 955 | 26359406 |
US |
67 | 1 |
Parkinson^s disease, Cardiac disorder, Incorrect disposal of product, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 956 | 26359649 |
US |
2 | |
Drug dose omission by device, Device defective, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 957 | 26359751 |
US |
||
Wheezing, Drug dose omission by device, Device issue, Device dispensing error, |
||||
ALBUTEROL SULFATE, |
||||
| 958 | 26360141 |
US |
||
Drug dose omission by device, Device delivery system issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 959 | 26360219 |
US |
||
Device delivery system issue, Incorrect dose administered by device, Drug dose omission by device, Eye disorder, Extra dose administered, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 960 | 26360700 |
US |
8 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 961 | 26360726 |
GB |
59 | 2 |
Device leakage, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 962 | 26360730 |
US |
12 | 1 |
Drug dose omission by device, Device mechanical issue, Device leakage, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, SOMATROPIN, SOMATROPIN, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 963 | 26360732 |
US |
3 | 2 |
Drug dose omission by device, Device use error, Device breakage, |
||||
SOMATROPIN, |
||||
| 964 | 26360733 |
US |
17 | 1 |
Drug dose omission by device, Device mechanical issue, Device defective, |
||||
SOMATROPIN, |
||||
| 965 | 26360752 |
CO |
2 | |
Drug dose omission by device, Device physical property issue, |
||||
SOMATROPIN, |
||||
| 966 | 26360753 |
CO |
1 | |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 967 | 26360754 |
CO |
1 | |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 968 | 26360789 |
US |
14 | 1 |
Drug dose omission by device, Device defective, |
||||
SOMATROPIN, |
||||
| 969 | 26361409 |
US |
53 | 2 |
Nausea, Device difficult to use, Drug dose omission by device, |
||||
ERENUMAB-AOOE, |
||||
| 970 | 26361469 |
BR |
39 | 2 |
Seizure, Loss of consciousness, Headache, Dyspnoea, Malaise, Injection site erythema, Drug dose omission by device, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TRAZODONE HYDROCHLORIDE, |
||||
| 971 | 26361477 |
US |
10 | 2 |
Blood growth hormone decreased, Drug dose omission by device, Device mechanical issue, Device physical property issue, |
||||
SOMATROPIN, |
||||
| 972 | 26361483 |
CO |
1 | |
Device mechanical issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 973 | 26361494 |
UY |
14 | 2 |
Drug dose omission by device, Device mechanical issue, Device information output issue, Product dose omission issue, |
||||
SOMATROPIN, |
||||
| 974 | 26361496 |
KR |
9 | 1 |
Poor quality product administered, Drug dose omission by device, Product communication issue, Product contamination physical, Device chemical property issue, |
||||
SOMATROPIN, |
||||
| 975 | 26361497 |
US |
47 | 1 |
Drug dose omission by device, Device use error, Device breakage, Device physical property issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 976 | 26361668 |
US |
2 | |
Cardiac disorder, Infection, Device use issue, Drug dose omission by device, |
||||
DENOSUMAB, |
||||
| 977 | 26362061 |
EU |
2 | |
Device breakage, Drug dose omission by device, Hypoglycaemia, |
||||
| 978 | 26351683 |
US |
53 | 1 |
Device occlusion, Drug dose omission by device, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 979 | 26352045 |
US |
64 | |
Drug dose omission by device, Product packaging issue, No adverse event, |
||||
TIOTROPIUM BROMIDE, TREPROSTINIL, |
||||
| 980 | 26352052 |
US |
||
Chest discomfort, Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 981 | 26352511 |
US |
2 | |
Asthma, Drug dose omission by device, Device defective, Needle issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 982 | 26352572 |
US |
55 | 2 |
Hidradenitis, Condition aggravated, Drug dose omission by device, Device malfunction, Needle issue, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 983 | 26352573 |
IL |
1 | |
Cerebrovascular accident, Device delivery system issue, Drug dose omission by device, Wrong technique in product usage process, Illness, Cardiac disorder, |
||||
| 984 | 26352703 |
US |
||
Drug dose omission by device, Device mechanical issue, |
||||
LEUPROLIDE ACETATE, |
||||
| 985 | 26352750 |
US |
66 | 2 |
Herpes simplex, Alopecia, Device malfunction, Illness, Oropharyngeal pain, Epistaxis, Gastrooesophageal reflux disease, Feeling abnormal, Sinusitis, Bronchitis, Throat irritation, Drug dose omission by device, |
||||
OFATUMUMAB, OFATUMUMAB, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 986 | 26353669 |
US |
61 | 1 |
Drug dose omission by device, Blood glucose increased, Malaise, |
||||
INSULIN LISPRO, |
||||
| 987 | 26353828 |
US |
2 | |
Product use issue, Drug dose omission by device, Device defective, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 988 | 26353935 |
US |
70 | 2 |
Drug dose omission by device, Device defective, |
||||
ALBUTEROL SULFATE, |
||||
| 989 | 26354255 |
US |
75 | |
Wheezing, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, MONTELUKAST SODIUM, LISINOPRIL, |
||||
| 990 | 26354310 |
44 | 2 | |
Device issue, Drug dose omission by device, |
||||
METRELEPTIN, |
||||
| 991 | 26354615 |
US |
72 | 1 |
Radiculopathy, Incorrect disposal of product, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 992 | 26354974 |
CO |
1 | |
Device leakage, Device issue, Drug dose omission by device, Pain in extremity, |
||||
SOMATROPIN, |
||||
| 993 | 26354978 |
US |
16 | 1 |
Drug dose omission by device, Device information output issue, Device power source issue, Device failure, |
||||
SOMATROPIN, |
||||
| 994 | 26354979 |
US |
11 | 2 |
Product preparation issue, Drug administered in wrong device, Device leakage, Wrong technique in device usage process, Drug dose omission by device, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, |
||||
| 995 | 26354989 |
US |
13 | 1 |
Device information output issue, Device power source issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 996 | 26354990 |
GB |
13 | 2 |
Device defective, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 997 | 26354997 |
GB |
56 | 2 |
Drug dose omission by device, Device issue, |
||||
ETANERCEPT, |
||||
| 998 | 26355011 |
CO |
2 | |
Device defective, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 999 | 26355683 |
US |
1 | |
Drug dose omission by device, Physical product label issue, Product delivery mechanism issue, |
||||
ALBUTEROL SULFATE, |
||||
| 1000 | 26355779 |
US |
35 | |
Exposure via skin contact, Device leakage, Drug dose omission by device, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28